Finance

Beta
Lists
EDSA:NASDAQ
Edesa Biotech Inc
၆.၇၂ US$
-၂.၁၈%
(-၀.၁၅) 1D
ဇူ ၁၆, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EDSA...
Open
၆.၈၅ US$
High
၆.၉၃ US$
Low
၆.၅၂ US$
Mkt. cap
၆.၄၇ ကုဋေ
Avg. vol.
၁.၆၆ သိန်း
Volume
၁.၀၀
52-wk high
၂၀.၃၂ US$
52-wk low
၀.၇၂ US$
EPS
-၁.၃၄ US$
Beta
၁.၀၃
Shares outstanding
၉.၆၃ သန်း
No. of employees
၁၇
Open
၆.၈၅ US$
High
၆.၉၃ US$
Low
၆.၅၂ US$
Mkt. cap
၆.၄၇ ကုဋေ
Avg. vol.
၁.၆၆ သိန်း
Volume
၁.၀၀
52-wk high
၂၀.၃၂ US$
52-wk low
၀.၇၂ US$
EPS
-၁.၃၄ US$
Beta
၁.၀၃
Shares outstanding
၉.၆၃ သန်း
No. of employees
၁၇
News stories
From sources across the web
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၃ မိနစ်
Enovix (NASDAQ:ENVX) Hits New 52-Week Low - Here's Why
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၄၈ မိနစ်
Nasdaq (NDAQ) Could Be 11% Undervalued As Earnings Expectations Build
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
El-Erian Flags ‘Fascinating’ Market Shift As Dow, S&P 500 Catch Up To Nasdaq
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၁ မိနစ်
Stock futures slide as chip stocks extend global rout (SPX:)
About Edesa Biotech Inc
CEOPar Nijhawan
Employees၁၇
Founded၂၀၀၇
Headquartersမာက်ဟမ်း, အွန်တေးရီးယိုးပြည်နယ်, ကနေဒါ
Sector-
Websiteedesabiotech.com
Analyst ratings
Based on 1 analyst giving stock ratings to EDSA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for EDSA in the last 3 months
Highest
Current ၆.၇၂ US$
၂၁.၀၀ US$ (+၂၁၂.၅၀%)
Average
၂၁.၀၀ US$ (+၂၁၂.၅၀%)
Lowest
၂၁.၀၀ US$ (+၂၁၂.၅၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kumaraguru Raja
Brookline Capital Markets
Buy
Initiated
၂၁.၀၀ US$
+၂၁၂.၅%
06/29/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
၅.၀၀ US$
-၂၅.၆%
11/03/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၉.၃၉ သိန်း
၁.၂၃ သန်း
၁.၁၂ သန်း
၂.၇၇ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၉.၆၅ သိန်း
၁.၂၄ သန်း
၁.၂၂ သန်း
၁.၅၃ သန်း
Operating expense
၁.၉၀ သန်း
၂.၄၇ သန်း
၂.၃၄ သန်း
၄.၃၀ သန်း
Total operating expenses
၁.၉၀ သန်း
၂.၄၇ သန်း
၂.၃၄ သန်း
၄.၃၀ သန်း
Operating income
-၁.၉၀ သန်း
-၂.၄၇ သန်း
-၂.၃၄ သန်း
-၄.၃၀ သန်း
Other non operating income
-
-
-
၆.၆၂ သောင်း
EBT including unusual items
-၁.၇၅ သန်း
-၂.၂၃ သန်း
-၂.၂၅ သန်း
-၄.၂၂ သန်း
EBT excluding unusual items
-၁.၉၃ သန်း
-၂.၄၈ သန်း
-၂.၃၅ သန်း
-၄.၂၂ သန်း
Income tax expense
-
-
-
၈၀၀.၀၀
Effective tax rate
-
-
-
-၀.၀၂%
Other operating expenses
-
-
-
-
Net income
-၁.၇၅ သန်း
-၂.၂၃ သန်း
-၂.၂၅ သန်း
-၄.၂၂ သန်း
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
၅၇၂.၀၀
၅၅.၀၀
၄၇.၀၀
၆၃၉.၀၀
Interest expense
-
-
-
-
Net interest expenses
၅၇၂.၀၀
၅၅.၀၀
၄၇.၀၀
၆၃၉.၀၀
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၈၈ သန်း
-၂.၄၄ သန်း
-၂.၃၂ သန်း
-၄.၂၇ သန်း
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer